Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4+ T-cell function

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5144-5147

  Touloukian, Christopher E ^a   Leitner, Wolfgang W ^a   Robbins, Paul F ^a   Li, Yong F ^a   Kang, Xiaoqiang ^a   Lapointe, Rejean ^a   Hwu, Patrick ^a   Rosenberg, Steven A ^a   Restifo, Nicholas P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; EPITOPE; TUMOR ANTIGEN; TYROSINASE RELATED PROTEIN 1;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MELANOMA; METASTASIS; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES; PROTEINS;

EID: 0037105742     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. The role of CD4+ T cell responses in antitumor immunity
2. CD4 T cells and their role in antitumor immune responses
3. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction
4. CD4(+). HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells
5. Immune escape of melanoma: First evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway
6. HLA class I antigen abnormalities and immune escape by malignant cells
7. Molecular mechanisms of activated T cell death in vivo
8. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
9. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
10. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
11. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity
12. Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance
13. Identification of a MHC class II-restricted human gp100 epitope using DR4-1E transgenic mice
14. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4(+) T lymphocytes
15. Coupling and uncoupling of tumor immunity and autoimmunity
16. Human melanoma cells do not express Fas (Apo-1/CD95) ligand
17. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: Evidence of in vivo priming by tumor cells